Predicting	O
MEK	B:C2347168
Inhibitor	I:C2347168
Response	O
in	O
Lung	O
Cancer	I:C0684249
:	O
A	O
Proper	O
Signature	O

Predicting	O
MEK	O
Inhibitor	I:C2347168
Response	O
in	O
Lung	B:C0684249
Cancer	I:C0684249
:	O
A	O
Proper	O
Signature	O

The	O
ERK	B:C0600388
signaling	O
pathway	I:C0037080
is	O
one	O
of	O
the	O
most	O
commonly	O
deregulated	O
pathways	I:C1514542
in	O
cancer	O
.	O

The	O
ERK	O
signaling	B:C0037080
pathway	I:C0037080
is	O
one	O
of	O
the	O
most	O
commonly	O
deregulated	O
pathways	I:C1514542
in	O
cancer	O
.	O

The	O
ERK	O
signaling	O
pathway	I:C0037080
is	O
one	O
of	O
the	O
most	O
commonly	O
deregulated	B:C1514542
pathways	I:C1514542
in	O
cancer	O
.	O

The	O
ERK	O
signaling	O
pathway	I:C0037080
is	O
one	O
of	O
the	O
most	O
commonly	O
deregulated	O
pathways	I:C1514542
in	O
cancer	B:C0007097
.	O

Assays	B:C1510438
that	O
accurately	O
measure	O
ERK	O
signaling	O
output	O
in	O
clinical	O
specimens	O
would	O
be	O
extremely	O
helpfu	I:C2984543
l	O
not	O
only	O
in	O
determining	O
the	O
pharmacodynamic	O
effects	O
of	O
drug	O
treatment	I:C0013216
but	O
also	O
in	O
selecting	O
those	O
patients	O
most	O
likely	O
to	O
respond	O
to	O
therapy	O
.	O

Assays	O
that	O
accurately	O
measure	O
ERK	B:C0600388
signaling	O
output	O
in	O
clinical	O
specimens	O
would	O
be	O
extremely	O
helpfu	I:C2984543
l	O
not	O
only	O
in	O
determining	O
the	O
pharmacodynamic	O
effects	O
of	O
drug	O
treatment	I:C0013216
but	O
also	O
in	O
selecting	O
those	O
patients	O
most	O
likely	O
to	O
respond	O
to	O
therapy	O
.	O

Assays	O
that	O
accurately	O
measure	O
ERK	O
signaling	B:C3537152
output	O
in	O
clinical	O
specimens	O
would	O
be	O
extremely	O
helpfu	I:C2984543
l	O
not	O
only	O
in	O
determining	O
the	O
pharmacodynamic	O
effects	O
of	O
drug	O
treatment	I:C0013216
but	O
also	O
in	O
selecting	O
those	O
patients	O
most	O
likely	O
to	O
respond	O
to	O
therapy	O
.	O

Assays	O
that	O
accurately	O
measure	O
ERK	O
signaling	O
output	O
in	O
clinical	O
specimens	O
would	O
be	O
extremely	B:C2984543
helpfu	I:C2984543
l	O
not	O
only	O
in	O
determining	O
the	O
pharmacodynamic	O
effects	O
of	O
drug	O
treatment	I:C0013216
but	O
also	O
in	O
selecting	O
those	O
patients	O
most	O
likely	O
to	O
respond	O
to	O
therapy	O
.	O

Assays	O
that	O
accurately	O
measure	O
ERK	O
signaling	O
output	O
in	O
clinical	O
specimens	O
would	O
be	O
extremely	O
helpfu	I:C2984543
l	O
not	O
only	O
in	O
determining	O
the	O
pharmacodynamic	B:C0851347
effects	O
of	O
drug	O
treatment	I:C0013216
but	O
also	O
in	O
selecting	O
those	O
patients	O
most	O
likely	O
to	O
respond	O
to	O
therapy	O
.	O

Assays	O
that	O
accurately	O
measure	O
ERK	O
signaling	O
output	O
in	O
clinical	O
specimens	O
would	O
be	O
extremely	O
helpfu	I:C2984543
l	O
not	O
only	O
in	O
determining	O
the	O
pharmacodynamic	O
effects	O
of	O
drug	B:C0013216
treatment	I:C0013216
but	O
also	O
in	O
selecting	O
those	O
patients	O
most	O
likely	O
to	O
respond	O
to	O
therapy	O
.	O

Assays	O
that	O
accurately	O
measure	O
ERK	O
signaling	O
output	O
in	O
clinical	O
specimens	O
would	O
be	O
extremely	O
helpfu	I:C2984543
l	O
not	O
only	O
in	O
determining	O
the	O
pharmacodynamic	O
effects	O
of	O
drug	O
treatment	I:C0013216
but	O
also	O
in	O
selecting	O
those	O
patients	O
most	O
likely	O
to	O
respond	O
to	O
therapy	B:C0087111
.	O

